Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 11, keine Gesamtzahl für „weeks“
Suchtreffer
Begriffe & Kennungen
Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) · 4.8 · In study MCL-002 there was overall an apparent increase in early (within 20 weeks) deaths. Patients with high
Eintrag öffnenLenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) · 4.8 · Most adverse reactions tended to occur during the first 16 weeks of therapy with lenalidomide. Serious adverse
Eintrag öffnenLenalidomide Mylan · 4.8 · In study MCL-002 there was overall an apparent increase in early (within 20 weeks) deaths. Patients with high
Eintrag öffnenLenalidomide Mylan · 4.8 · Most adverse reactions tended to occur during the first 16 weeks of therapy with lenalidomide.
Eintrag öffnenLenvima · 4.8 · 24 from two weeks to greater than 1 year from initiation of lenvatinib, with median latency of about 3 months.
Eintrag öffnenLenvima · 4.8 · The median time to first onset in lenvatinib-treated patients was 10.1 weeks. No differences between lenvatini
Eintrag öffnenLibmyris · 4.8 · During the controlled portions of pivotal adalimumab trials in adults of at least 12 weeks in duration in pati
Eintrag öffnenLibmyris · 4.8 · During the controlled portions of pivotal adalimumab trials in adults of at least 12 weeks in duration in pati
Eintrag öffnenLitfulo · 4.8 · Creatine phosphokinase (CPK) elevations In the placebo-controlled studies, for up to 24 weeks, events of blood
Eintrag öffnenLitfulo · 4.8 · Decreased lymphocyte count In the placebo-controlled studies, for up to 24 weeks, and study AA-I, for up to 48
Eintrag öffnenLitfulo · 4.8 · Decreased platelet count In the placebo-controlled studies, for up to 24 weeks, and study AA-I, for up to 48 w
Eintrag öffnenLitfulo · 4.8 · In the placebo-controlled studies, for up to 24 weeks, no serious infections were reported in patients treated
Eintrag öffnenLitfulo · 4.8 · Increased transaminases In the placebo-controlled studies, for up to 24 weeks, events of increases in ALT and
Eintrag öffnenLitfulo · 4.8 · Infections In the placebo-controlled studies, for up to 24 weeks, overall infections have been reported in 31%
Eintrag öffnenLupkynis · 4.8 · In the first 4 weeks of treatment with voclosporin, haemodynamic reductions in eGFR are commonly experienced,
Eintrag öffnenLynkuet · 4.8 · ALT and AST increased In the pooled safety data up to 52 weeks, the term ALT increased was reported in 0.6% of
Eintrag öffnenLynkuet · 4.8 · Photosensitivity reactions In the pooled safety data up to 52 weeks, photosensitivity reactions were reported
Eintrag öffnenMabThera · 4.8 · Haematologic adverse reactions In clinical trials with MabThera monotherapy given for 4 weeks, haematological
Eintrag öffnenMabThera · 4.8 · Haematologic adverse reactions In clinical trials with MabThera monotherapy given for 4 weeks, haematological
Eintrag öffnenMabThera · 4.8 · Haematologic adverse reactions In clinical trials with MabThera monotherapy given for 4 weeks, haematological
Eintrag öffnen